Julie Brahmer, MD of Johns Hopkins Kimmel Comprehensive Cancer Center gives her input on when patients should stop treatment. She states that if the patient shows responsive to treatment, then she would feel comfortable allowing the patient to stop early. She also explains whether or not all patients should have PD-L1 staining. This was recorded at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, DC.
When Should Patients Stop Treatment?
